Organization · Venture Capital
YuanBio Venture Capital
YuanBio Venture Capital is a healthcare-focused investment firm based in Suzhou, China, specializing in early and growth-stage companies. The firm has invested in over 200 companies in the life sciences sector, achieving significant returns with 19 companies going public.
Overview
What YuanBio Venture Capital does
What YuanBio Venture Capital is
YuanBio Venture Capital is a healthcare-focused investment firm based in Suzhou, China, specializing in early and growth-stage companies. The firm has invested in over 200 companies in the life sciences sector, achieving significant returns with 19 companies going public.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find YuanBio Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
YuanBio Venture Capital as a funder
Investment thesis
YuanBio Venture Capital focuses on healthcare-specialist venture investing in early and growth-stage companies, emphasizing high-growth markets and strong technical barriers.
Focus narrative
YuanBio Venture Capital primarily invests in the healthcare sector, targeting innovative companies involved in new drug development, medical devices, diagnostics, precision medicine, and healthcare services. The firm seeks to capitalize on early and growth-stage opportunities while maintaining a global perspective on healthcare advancements.
Value beyond capital
YuanBio Venture Capital adds value to its portfolio companies through strategic guidance, leveraging its extensive industry expertise and network. The firm focuses on supporting companies with strong teams and innovative technologies, aiming to foster growth and facilitate successful market entry.
Focus and fit
- Stages
- Angel · Pre-seed · Seed · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices · Digital Health · Precision Medicine
- Regions
- Global · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 200
- Recorded notable exits
- Ascentage Pharma, Henlius Biotech, Kintor Pharma, Basecare Medical, YHLO Biotech, and Quantum-Si, plus 1 more
Portfolio context
YuanBio Venture Capital has a diverse portfolio of over 200 companies in the life sciences sector. Notable portfolio companies include Ascentage Pharma, Henlius Biotech, Kintor Pharma, Basecare Medical, YHLO Biotech, Quantum-Si, Zylox-Tonbridge, AusperBio, Allink Biotherapeutics, and Xiaolu Biology, with many achieving public listings.
Common questions
What to know about YuanBio Venture Capital
Upseed classifies YuanBio Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.